Hanjun Zhao

Title: Hanjun Zhao: Innovator in Antiviral Peptide Development

Introduction

Hanjun Zhao is a notable inventor based in Hong Kong, China. He has made significant contributions to the field of antiviral research, particularly in the development of peptides that inhibit respiratory virus infections. With a total of two patents to his name, Zhao's work is paving the way for new therapeutic agents.

Latest Patents

Hanjun Zhao's latest patents include a method for preventively treating subjects at risk of developing infections from respiratory viruses. This method involves administering an effective amount of a peptide that can bind to the surface glycoprotein of respiratory viruses, thereby inhibiting their infection. The peptide is characterized by having five or more basic amino acids, with at least two located in the N-terminal or C-terminal regions. Additionally, Zhao has developed peptides that can block infections of respiratory viruses in target cells, which are useful for both prevention and treatment. These innovations provide theoretical support for the development of new broad-spectrum antiviral agents.

Career Highlights

Throughout his career, Hanjun Zhao has worked with Xiangxue Group (Hong Kong) Company Limited, where he has contributed to various research initiatives. His work has focused on synthesizing peptides through chemical and genetic engineering methods, enhancing the potential for new therapeutic applications.

Collaborations

Hanjun Zhao has collaborated with Bojian Zheng, furthering research in the field of antiviral peptides. Their combined efforts aim to advance the understanding and application of peptide-based treatments.

Conclusion

Hanjun Zhao's innovative work in the development of antiviral peptides represents a significant advancement in the fight against respiratory viruses. His contributions are essential for the future of therapeutic interventions in this critical area of health.